Stryker Corp (SYK)

Surgical & Medical Instruments & Apparatus

Latest Price

$275.39

TTM P/E

28.54

Normalized P/E

34.85

Div Yield

0.94%

Book Value

62.54

P/B Ratio

4.40

Valuation metrics

EPS: $8.40

Book value / share: $58.01

Formula: √(22.5 × EPS × BVPS)

Graham Number

$104.71

62% downside

Norm. op. income: $2.8B (median of 7yr)

Tax rate: 14%

Discount rate: 10%

Growth assumption: zero (EPV is a no-growth value)

Earnings Power Value

$32.35

88% downside

Base FCF: $3.1B (median of recent 5yr)

Growth: 17%/yr (median YOY, capped at 25%)

Discount rate: 10%

Terminal growth: 3%

Projection horizon: 10 years

DCF Fair Value

$306.57

+11% upside

EPS: $8.40

Target P/E: 35×

Formula: EPS × P/E

P/E Fair Value

$294.00

+7% upside

78.7% held by institutions

Institution	Shares	Value	Ownership %	Change	Filing Date
BlackRock, Inc.	27.41M	$8.63B	7.15%	-187.3K	2026-06-30
Vanguard Capital Management LLC	22.54M	$7.09B	5.88%	+153.7K	2026-06-30
JPMorgan Chase & Co	17.26M	$5.71B	4.50%	+5.12M	2026-06-30
State Street Corp	15.53M	$4.90B	4.05%	+183.4K	2026-06-30
Greenleaf Trust	15.23M	$4.79B	3.97%	-709.5K	2026-06-30
Price T Rowe Associates Inc	11.92M	$3.75B	3.11%	+1.88M	2026-06-30
Vanguard Portfolio Management LLC	8.17M	$2.57B	2.13%	-161.1K	2026-06-30
Wellington Management Group LLP	8.17M	$2.57B	2.13%	+45.5K	2026-06-30
Geode Capital Management, LLC	7.82M	$2.45B	2.04%	+71.5K	2026-06-30
Morgan Stanley	5.96M	$1.88B	1.56%	-336.8K	2026-06-30